A preclinical mouse study in 2020 demonstrated that radiotherapy induced the release of neoantigens, which when combined with neoantigen vaccines, led to the expansion of neoantigen-specific CD4+T cells and CD8+T cells, significantly enhancing the anti-tumor effect (18). The gene discussed is CD8A; the disease is neoplasm.